Metropolitan Life Insurance Company (MetLife)’s Broadcom AVGO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AVGO Stock Details AVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-177,500	Closed	-$23.5M	–	216
2024 Q1	$23.5M	Sell	177,500 -1,180	-0.7%	-$146K	1.02%	15
2023 Q4	$19.9M	Buy	178,680 +7,930	+5%	+$751K	0.94%	16
2023 Q3	$14.2M	Sell	170,750 -10,950	-6%	-$949K	0.74%	22
2023 Q2	$15.8M	Sell	181,700 -5,220	-3%	-$372K	0.77%	21
2023 Q1	$12M	Sell	186,920 -41,650	-18%	-$2.51M	0.62%	27
2022 Q4	$12.8M	Sell	228,570 -6,990	-3%	-$350K	0.57%	31
2022 Q3	$10.5M	Sell	235,560 -5,470	-2%	-$279K	0.5%	33
2022 Q2	$11.7M	Sell	241,030 -8,820	-4%	-$495K	0.51%	33
2022 Q1	$15.7M	Sell	249,850 -399,570	-62%	-$23.7M	0.56%	26
2021 Q4	$43.2M	Sell	649,420 -13,420	-2%	-$754K	0.59%	19
2021 Q3	$32.1M	Sell	662,840 -19,980	-3%	-$972K	0.47%	27
2021 Q2	$32.6M	Sell	682,820 -8,680	-1%	-$402K	0.46%	28
2021 Q1	$32.1M	Sell	691,500 -35,980	-5%	-$1.66M	0.48%	28
2020 Q4	$31.9M	Sell	727,480 -19,660	-3%	-$766K	0.48%	31
2020 Q3	$27.2M	Sell	747,140 -27,740	-4%	-$929K	0.46%	38
2020 Q2	$24.5M	Buy	774,880 +11,010	+1%	+$308K	0.43%	41
2020 Q1	$18.1M	Sell	763,870 -10,840	-1%	-$305K	0.37%	52
2019 Q4	$24.5M	Sell	774,710 -5,870	-0.8%	-$178K	0.39%	47
2019 Q3	$21.5M	Buy	780,580 +70,960	+10%	+$2.02M	0.37%	51
2019 Q2	$20.4M	Buy	709,620 +42,150	+6%	+$1.23M	0.34%	52
2019 Q1	$20.1M	Sell	667,470 -50,910	-7%	-$1.38M	0.36%	49
2018 Q4	$18.3M	Sell	718,380 -24,160	-3%	-$570K	0.37%	49
2018 Q3	$18.3M	Buy	+742,540	New	+$16.7M	0.31%	62
2014 Q3	–	Sell	-1,541,020	Closed	-$10.9M	–	2668
2014 Q2	$10.9M	Buy	1,541,020 +1,379,990	+857%	+$9.26M	0.08%	262
2014 Q1	$1.04M	Hold	161,030	–	–	0.01%	1321
2013 Q4	$852K	Hold	161,030	–	–	0.01%	1443
2013 Q3	$694K	Sell	161,030 -1,870	-1%	-$7.18K	0.01%	1532
2013 Q2	$609K	Buy	+162,900	New	+$568K	﹤0.01%	1569

Other funds holding AVGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AVGO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Broadcom (AVGO) in Q2 2024, closing a stake of 177,500 shares — an estimated $23.5M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AVGO in Q2 2013 and held it in 28 quarters. The position peaked at $43.2M in Q4 2021. 3,272 funds tracked by Wall St. Rank hold AVGO as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Broadcom position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 177,500 Broadcom shares in Q2 2024, an estimated $23.5M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Broadcom in Q2 2013 and held it in 28 quarters.
Metropolitan Life Insurance Company (MetLife)'s Broadcom position peaked at $43.2M in Q4 2021.
3,272 funds tracked by Wall St. Rank held Broadcom as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.